ASGCT 2024: Advanced Therapies Abstract Highlights
This report offers a comprehensive analysis of the following key areas:
Comprehensive Analysis: Detailed review of the Advanced Therapies landscape with over 12,000 assets tracked, including the development status of each.
Abstract Review: In-depth analysis of preclinical, clinical, and trial outline abstracts.
Therapeutic Modality Breakdown: Examination of therapeutic classes, diseases, and targets with a focus on solid tumors.
Exclusive Insights: Overlap and interconnections between various Advanced Therapies.
You May Also Be Interested In…
Learn More About Cell Therapy
- The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
- Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
